In recognition for the projects with a local or community focus and their benefits to patient care, the Gilead Australia Fellowship: Grants Program aims to help bridge the gap in local Australian research funding.
Gilead is committed to supporting innovative local research initiatives to improve patient outcomes. The Grants Program enables Australian researchers to apply for funding across a range of therapeutic areas.
The Program aims to support:
- projects with a clinical and ‘real-world’ focus
- the development and implementation of best practice to enhance patient outcomes
- research in the specific disease areas of HIV and/or chronic viral hepatitis, haematological malignancies, solid tumours (especially breast, lung and bladder), and invasive fungal infections.
The total funding available for the 2023 Grants Program is $300,000 AUD. The requested level of funding should be stated at the time of application.*
Funding is contingent on the project:
- being granted ethics approval (if required)
- concluding in no more than 18 months after execution of agreement.
*A maximum award for successful proposals will be $60k. The exact amount of funding allocated to each project may vary depending on the nature of the project. Funding is entirely independent of the use of any particular therapeutic agent.
Applications are now open, and close Friday 12 August 2022. For more information and to apply, click here: www.gileadfellowship.com.au